Cost of new Alzheimer’s drug remains a hurdle

The first new drug to treat Alzheimer’s disease in two decades was approved by the FDA in June and it’s finally starting to reach patients, though most Iowans won’t be able to afford it — at least not yet. Lauren Livingston, spokeswoman for the Iowa Chapter of the Alzheimer’s Association, says it’s encouraging that the […]